Favipiravir Impurity 16 | CAS 259793-88-9 - Request Quote
Favipiravir Impurity 16
| SZ CAT No: | SZ-F056019 |
| CAS No | 259793-88-9 |
| Mol.F. | C5H4BrN3O2 |
| Mol.Wt. | 218.0 |
| Inv. Status | Under QC Approval |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Favipiravir Impurity 16 is chemically 6-Bromo-3-hydroxypyrazine-2-carboxamide. Favipiravir Impurity 16 is supplied with detailed characterization data compliant with regulatory guideline. Favipiravir Impurity 16 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Favipiravir.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 259793-88-9
Purchase 259793-88-9
Order 259793-88-9
Enquire 259793-88-9
price of 259793-88-9
259793-88-9 Supplier
259793-88-9 Manufacturer
259793-88-9 Exporter
buy high quality Favipiravir Impurity 16
Purchase Favipiravir Impurity 16
Favipiravir Impurity 16 suppliers
Favipiravir Impurity 16 manufacturers
Favipiravir Impurity 16 price
Order Favipiravir Impurity 16
Enquire Favipiravir Impurity 16
Favipiravir Impurity 16 cost
Favipiravir Impurity 16 Supplier
Favipiravir Impurity 16 Distributor
Favipiravir Impurity 16 for Method Validation
Favipiravir Reference Standard
Favipiravir Impurity 16 for ANDA Filing
Favipiravir Impurity 16 for Forced Degradation Studies
Favipiravir Impurity 16 Identification Standards
Favipiravir Impurity 16 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.


